Diffusion Pharmaceuticals Inc. News - DFFN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc. DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.12 5.00% 2.52 2.72 2.32 2.38 2.40 18:00:07
more quote information »

Recent News

Date Time Source Heading
7/18/20197:32IHNWPromotedYield Growth Appoints Former Aritzia VP Operations Tamara Melck as Chief Operating Officer
6/13/201912:30EDGARCurrent Report Filing (8-k)
6/03/201917:23EDGARStatement of Ownership (sc 13g)
6/03/201916:45EDGARSmall Company Offering and Sale of Securities Without..
6/03/201908:40EDGARStatement of Ownership (sc 13g)
5/28/201916:45EDGARCurrent Report Filing (8-k)
5/28/201916:05GLOBEDiffusion Pharmaceuticals Inc. Announces Closing of $6.45..
5/28/201914:59EDGARStatement of Ownership (sc 13g)
5/28/201908:27EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/24/201909:00GLOBEDiffusion Pharmaceuticals Inc. Announces $6.45 Million..
5/23/201907:30GLOBEDiffusion Pharmaceuticals Receives Notice of Intention to..
5/23/201906:02EDGARNotice of Effectiveness (effect)
5/16/201916:43EDGARSecurities Registration Statement (simplified Form) (s-3)
5/09/201916:05EDGARCurrent Report Filing (8-k)
5/09/201916:05GLOBEDiffusion Pharmaceuticals Reports First Quarter 2019..
5/09/201916:03EDGARQuarterly Report (10-q)
4/30/201916:38EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/30/201916:36EDGARProxy Statement (definitive) (def 14a)
3/20/201909:00GLOBEDiffusion Pharmaceuticals Reports 2018 Financial Results and..
3/19/201914:51EDGARAnnual Report (10-k)
2/11/201916:00GLOBEPoster Presented at International Stroke Conference..
1/30/201909:07EDGARStatement of Changes in Beneficial Ownership (4)
1/18/201916:06EDGARCurrent Report Filing (8-k)
1/04/201916:04EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201909:00GLOBEDiffusion Pharmaceuticals Chief Executive Officer David..
1/03/201909:00GLOBEDiffusion Pharmaceuticals Executes Successful NASDAQ..
12/17/201809:55GLOBEU.S. Patent Office Awards Diffusion Exclusive Rights for Use..
12/14/201808:34EDGARCurrent Report Filing (8-k)
12/13/201814:00GLOBEDiffusion Pharmaceuticals Announces 1-for-15 Reverse Stock..
11/15/201809:15GLOBEDiffusion Pharmaceuticals Chief Scientific Officer Dr. John..
11/14/201816:07EDGARCurrent Report Filing (8-k)
11/14/201809:00GLOBEDiffusion Pharmaceuticals Reports Third Quarter 2018..
11/13/201816:10EDGARQuarterly Report (10-q)
10/15/201812:00GLOBEDiffusion Pharmaceuticals Chief Financial Officer William..
10/03/201816:24EDGARInitial Statement of Beneficial Ownership (3)
9/27/201816:03EDGARCurrent Report Filing (8-k)
9/25/201809:00GLOBEDiffusion Names William (“Bill”) Hornung Chief Financial..
9/12/201809:00GLOBEFDA Approves Start of Innovative On-Ambulance Phase 2..
8/31/201816:08EDGARCurrent Report Filing (8-k)
8/29/201808:00GLOBEDiffusion Pharmaceuticals to Present at the 20th Annual..
8/14/201816:30EDGARCurrent Report Filing (8-k)
8/13/201808:30GLOBEDiffusion Pharmaceuticals Reports Second Quarter 2018..
8/10/201816:23EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/10/201816:10EDGARQuarterly Report (10-q)
See more news about this stock »


Your Recent History
NASDAQ
DFFN
Diffusion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.